SG Americas Securities’s Pliant Therapeutics PLRX Stock Holding History

SG Americas Securities’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,604	Closed	-$16K	–	3608
2026 Q1	$16K	Buy	12,604 +343	+3%	+$433	﹤0.01%	3117
2025 Q4	$15K	Sell	12,261 -4,522	-27%	-$6.79K	﹤0.01%	3489
2025 Q3	$25K	Sell	16,783 -12,582	-43%	-$19.2K	﹤0.01%	3271
2025 Q2	$34K	Sell	29,365 -11,279	-28%	-$15.9K	﹤0.01%	2794
2025 Q1	$55K	Buy	40,644 +9,915	+32%	+$60.2K	﹤0.01%	3221
2024 Q4	$405K	Buy	30,729 +6,579	+27%	+$89.8K	﹤0.01%	1524
2024 Q3	$271K	Sell	24,150 -21,741	-47%	-$272K	﹤0.01%	2234
2024 Q2	$493K	Buy	45,891 +38,679	+536%	+$499K	﹤0.01%	1691
2024 Q1	$107K	Buy	+7,212	New	+$119K	﹤0.01%	2506
2021 Q4	–	Sell	-11,225	Closed	-$189K	–	3716
2021 Q3	$189K	Buy	+11,225	New	+$238K	﹤0.01%	3270
2021 Q2	–	Sell	-4,553	Closed	-$179K	–	3154
2021 Q1	$179K	Buy	+4,553	New	+$148K	﹤0.01%	2745

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SG Americas Securities's PLRX Position: Q2 2026 in Review

SG Americas Securities sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 12,604 shares — an estimated $16K sold.

SG Americas Securities first reported a position in PLRX in Q1 2021 and held it in 11 quarters. The position peaked at $493K in Q2 2024. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

SG Americas Securities reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
SG Americas Securities sold 12,604 Pliant Therapeutics shares in Q2 2026, an estimated $16K.
SG Americas Securities first reported a position in Pliant Therapeutics in Q1 2021 and held it in 11 quarters.
SG Americas Securities's Pliant Therapeutics position peaked at $493K in Q2 2024.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.